• The drug works…but why?

    Veronica Meade-Kelly, December 11th, 2013

    What: A team led by Broad scientists has uncovered how the cancer drug lenalidomide works. Lenalidomide has been used for nearly a decade to treat multiple myeloma and other disorders that affect blood cells found in bone marrow, but its exact mechanism of action hadn’t previously been understood.

    Read More
  • Holiday closing from Dec. 23, 2013 to Jan. 1, 2014

    Haley Bridger, December 6th, 2013

    To give employees ample time to celebrate the holidays with friends and family, the Broad Institute will close from Monday, December 23, 2013 to Wednesday, January 1, 2014. It will reopen on Thursday, January 2, 2014.

    Our websites, of course, will still be up and running during the closing, allowing researchers all over the globe to continue accessing data, software, tools, and more.

    Read More
  • Broad announces new Merkin Institute Fellows

    Paul Goldsmith, November 22nd, 2013

    The Broad Institute is pleased to announce the latest class of Merkin Institute Fellows. The Broad’s first endowed fellowship, the Merkin Institute Fellows program was established in 2012 by Dr. Richard Merkin to provides sustained support for some of the most promising and ambitious scientists pursuing bold research at the Broad. The 2013-2014 recipients represent three of the Broad’s fastest rising stars: Sangeeta Bhatia, John Doench, and Angela Koehler.

    Read More
  • Broad stays at the top

    Veronica Meade-Kelly, November 19th, 2013

    The Boston Globe has once again listed the Broad Institute among the “Top Places to Work” in Massachusetts. It is the fourth year in a row that the institute, which prides itself on its interdisciplinary community and collaborative spirit, has earned the honor, which recognizes workplace satisfaction.

    Read More
  • A new phase for the microbiome

    Leah Eisenstadt, November 6th, 2013

    For the last five years, scientists at the Broad Institute have been helping generate a catalog of the trillions of microorganisms living on – and in – the human body. We now know that these passengers, collectively known as the microbiome, are not merely cargo; they have physiologic effects, both positive and detrimental, on their human hosts.

    Read More
  • Insights into OCD and Tourette syndrome

    Haley Bridger, October 28th, 2013

    What: Researchers are beginning to probe the underlying genetic basis of obsessive compulsive disorder (OCD) and Tourette syndrome (TS), two neuropsychiatric disorders that frequently co-occur in families.

    Read More
  • Fighting cancer with some help from our (best) friends

    Paul Goldsmith, October 11th, 2013

    Sit. Fetch. Roll-over. Humans have been trying to teach dogs for tens of thousands of years. But when it comes to the genetics of cancer, it turns out dogs have a lot to teach us, as well.

    Different as we may seem, humans and dogs are genetically-speaking quite similar. Almost all canine genes have a matching gene in the human genome. Given this correlation, it’s no surprise that dogs suffer from many of the same genetic disorders as human, including cancer.

    Read More
  • Broad’s websites will be unavailable Oct. 17 – 20

    Haley Bridger, October 8th, 2013

    Upddate, Oct. 20: We're happy to report that our IT team has made impressive progress over the weekend and our external facing web pages are now back up and running. For updates on other services, please follow the tweets from @broadsystems.

    Read More
  • TEDxCambridge: Decoding a Genomic Revolution

    Paul Goldsmith, October 2nd, 2013

    In his September 13, TEDxCambridge lecture, ‘Decoding a Genomic Revolution,’ Broad associate member and MIT associate professor Manolis Kellis used details from his own genome to demonstrate how science can bridge the gap between genetic variants and disease.

    Check out the video below and accompany Kellis on a journey into his personal genome to find out how recent discoveries could change the future of medical care.

    Read More
  • Levi Garraway awarded Paul Marks Prize for Cancer Research

    Veronica Meade-Kelly, September 26th, 2013

    Broad senior associate member Levi Garraway is one of three young investigators to receive this year’s Paul Marks Prize for Cancer Research. The award is bestowed every other year by Memorial Sloan-Kettering Cancer Center to promising scientists under the age of 45 in recognition of their contributions to cancer research.

    Read More